Kinetic analysis of mutual metabolic inhibition of lidocaine and propranolol in rat liver musomes
- 1 April 1993
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 45 (7) , 1528-1530
- https://doi.org/10.1016/0006-2952(93)90055-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Induction of propranolol metabolism by the azo dye sudan III in ratsBiochemical Pharmacology, 1992
- A possible mechanism of the impairment of hepatic microsomal monooxygenase activities after multiple administration of propranolol in ratsBiochemical Pharmacology, 1992
- Selective 3-hydroxylation deficiency of lidocaine and its metabolite in Dark Agouti ratsBiochemical Pharmacology, 1991
- Impairment of debrisoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranololBiochemical Pharmacology, 1991
- Inhibition of lignocaine metabolism by β-adrenoceptor antagonists in rat and human liver microsomesXenobiotica, 1989
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Animal modelling of human polymorphic drug oxidation—the metabolism of debrisoquine and phenacetin in rat inbred strainsJournal of Pharmacy and Pharmacology, 1981
- Ring-hydroxylated propranolol: synthesis and .beta.-receptor antagonist and vasodilating activities of the seven isomersJournal of Medicinal Chemistry, 1981
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- Quantification of Lidocaine and Several Metabolites Utilizing Chemical-Ionization Mass Spectrometry and Stable Isotope LabelingJournal of Pharmaceutical Sciences, 1977